You can now submit reviews for your favorite Tocris products. Your review will help other researchers decide on the best products for their research. Why not submit a review today?!Submit Review
Biological Activity for SC 26196
SC 26196 is a selective fatty acid desaturase 2 (FADS2, also known as Δ6 desaturase) inhibitor (IC50 = 0.2 μM in vitro). Displays selectivity over FADS1 and stearoly-CoA 9-desaturase (Δ5 desaturase and SCD-1/Δ9 desaturase, respectively) (IC50 values are >200 μM in vitro). Exhibits anti-inflammatory properties in a mouse edema model. Eliminates CSCs from ovarian cancer cell lines and inhibits sphere formation in vitro.
Sold for research purposes under agreement from Pfizer Inc.
Compound Libraries for SC 26196
Technical Data for SC 26196
|Storage||Store at -20°C|
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
Tocris products are intended for laboratory research use only, unless stated otherwise.
Solubility Data for SC 26196
|Solvent||Max Conc. mg/mL||Max Conc. mM|
Preparing Stock Solutions for SC 26196
The following data is based on the product molecular weight 423.55. Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.
|Concentration / Solvent Volume / Mass||1 mg||5 mg||10 mg|
|0.25 mM||9.44 mL||47.22 mL||94.44 mL|
|1.25 mM||1.89 mL||9.44 mL||18.89 mL|
|2.5 mM||0.94 mL||4.72 mL||9.44 mL|
|12.5 mM||0.19 mL||0.94 mL||1.89 mL|
References for SC 26196
References are publications that support the biological activity of the product.
Obukowicz et al (1998) Novel, selective Δ6 or Δ5 fatty acid desaturase inhibitors as antiinflammatory agents in mice. J.Pharmacol.Exp.Ther. 287 157 PMID: 9765335
Hansen-Petrik et al (2002) Selective inhibition of delta-6 desaturase impedes intestinal tumorigenesis. Cancer Lett. 175 157 PMID: 11741743
Zhang et al (2010) A multiplexed cell assay in HepG2 cells for the identification of delta-5, delta-6, and delta-9 desaturase and elongase inhibitors. J.Biomol.Screen. 15 169 PMID: 20086206
Li et al (2017) Lipid desaturation is a metabolic marker and therapeutic target of ovarian cancer stem cells. Cell Stem Cell 20 1 PMID: 28041894
If you know of a relevant reference for SC 26196, please let us know.
View Related Products by Target
View Related Products by Product Action
Keywords: SC 26196, SC 26196 supplier, Pfizer, SC26196, desaturases, delta6, d6, Δ6, selective, inhibitors, inhibits, anti-inflammatory, fatty, acid, metabolism, Other, Lipid, Metabolism, Cancer, Stem, Cells, Oxygenases/Oxidases, 4189, Tocris Bioscience
2 Citations for SC 26196
Citations are publications that use Tocris products. Selected citations for SC 26196 include:
Rui et al (2021) Integrated transcriptomic analysis of human tuberculosis granulomas and a biomimetic model identifies therapeutic targets. J Clin Invest 131 PMID: 34128839
Rees et al (2016) Correlating chemical sensitivity and basal gene expression reveals mechanism of action. PLoS One 12 109 PMID: 26656090
Do you know of a great paper that uses SC 26196 from Tocris? Please let us know.
Reviews for SC 26196
There are currently no reviews for this product. Be the first to review SC 26196 and earn rewards!
Have you used SC 26196?
Submit a review and receive an Amazon gift card.
$50/€35/£30/$50CAN/¥300 Yuan/¥5000 Yen for first to review with an image
$25/€18/£15/$25CAN/¥75 Yuan/¥1250 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image